Pravastatin (marketed as Pravachol or Selektine) is a member of the drug class of statins, used in combination with diet, exercise, and weight loss for lowering cholesterol and preventing cardiovascular disease.

The global Pravastatin market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Pravastatin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pravastatin market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Pravastatin in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Pravastatin manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Bristol-Myers Squibb
TEVA
SANDOZ
APOTEX
Dr. Reddy's Laboratories
Zydus Pharmaceuticals
Cipla Inc.
Lupin Pharmaceuticals
Glenmark
Mylan
Aurobindo Pharma
Accord Healthcare
Upsher-Smith Laboratories
Hisun
Jiangxi Boyaseehot Pharmaceutical
Shanghai Shyndec Pharmaceutical
Daiichi Sankyo
North China Pharmaceutical Group

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
10mg tablet
20mg tablet
40mg tablet
80mg tablet

Segment by Application
Adults
Children